Schiff Hardin advised BK Medical on the deal. Latham & Watkins represented Altaris Capital. GE Healthcare has entered into an agreement to acquire BK Medical, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented PROCEPT in the transaction. PROCEPT BioRobotics Corporation, a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Definitive Healthcare Corp., an industry leader in healthcare commercial intelligence, has announced the pricing of its initial public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Goldfarb Seligman & Co. represented Itamar Medical in the transaction. Cooley and Gornitzky & Co. advised ZOLL Medical. Itamar™ Medical Ltd. (Nasdaq...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Mazanti-Andersen represented Ascendis Pharma A/S in the transaction. Ascendis Pharma A/S (Nasdaq: ASND) has announced the pricing of its underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Desktop Metal in the transaction. Desktop Metal, Inc. (NYSE: DM) and The ExOne Company (NASDAQ: XONE) have entered into a definitive...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP is serving as legal advisor to Inovalon and the Special Committee of the Board of Directors of Inovalon. Kirkland & Ellis represented...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ginger on the deal, while Latham & Watkins represented Headspace. Ginger, a leading provider of on-demand mental healthcare, and Headspace, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and Wilson Sonsini Goodrich & Rosati represented Erasca in the transaction. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises the Underwriters in the offering while Cooley LLP represented Lyell Immunopharma. Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company...
You must be a Standard 1 Year member to access this content.
